Home
Finally, Gene Editing Therapy Has Been Approved! So Why the Stock Selloff?

Finally, Gene Editing Therapy Has Been Approved! So Why the Stock Selloff?

Impacting News December 11, 2023

Crispr Therapeutics and Vertex Pharmaceuticals Gene Editing Therapey Will Be Marketed
On Nov. 16, 2023, Crispr Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX)

This content is for paid subscribers.
Please click here to subscribe or here to log in.
Impacting News
,
December 11, 2023

Other Articles